{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2023-N-0061\" sorted by posted_date descending", "rows": [["FDA-2023-N-0061-0050", "FDA", "FDA-2023-N-0061", "TAB C - 2013-930-Drug Products-PRIA-FINAL", "Supporting & Related Material", "Background Material", "2024-11-06T05:00:00Z", 2024, 11, null, null, "2024-11-06T17:02:05Z", null, 0, 0, "0900006486800148"], ["FDA-2023-N-0061-0045", "FDA", "FDA-2023-N-0061", "TAB A - 2013-930-Drug Products-Proposed Rule-ORIGINAL", "Supporting & Related Material", "Background Material", "2024-11-06T05:00:00Z", 2024, 11, null, null, "2024-11-06T17:01:31Z", null, 0, 0, "0900006486800149"], ["FDA-2023-N-0061-0049", "FDA", "FDA-2023-N-0061", "TAB B - 2013-930-Drug Products-PRIA-TRACK CHANGE FROM ORIGINAL TO FINAL", "Supporting & Related Material", "Background Material", "2024-11-06T05:00:00Z", 2024, 11, null, null, "2024-11-06T17:01:59Z", null, 0, 0, "0900006486800147"], ["FDA-2023-N-0061-0046", "FDA", "FDA-2023-N-0061", "TAB B - 2013-930-Drug Products-Proposed Rule-TRACK CHANGE FROM ORIGINAL TO FINAL", "Supporting & Related Material", "Background Material", "2024-11-06T05:00:00Z", 2024, 11, null, null, "2024-11-06T17:01:38Z", null, 0, 0, "090000648680014a"], ["FDA-2023-N-0061-0048", "FDA", "FDA-2023-N-0061", "TAB A - 2013-930-Drug Products-PRIA-ORIGINAL", "Supporting & Related Material", "Background Material", "2024-11-06T05:00:00Z", 2024, 11, null, null, "2024-11-06T17:01:54Z", null, 0, 0, "0900006486800144"], ["FDA-2023-N-0061-0047", "FDA", "FDA-2023-N-0061", "TAB C - 2013-930-Drug Products-Proposed Rule-FINAL", "Supporting & Related Material", "Background Material", "2024-11-06T05:00:00Z", 2024, 11, null, null, "2024-11-06T17:01:44Z", null, 0, 0, "090000648680014b"], ["FDA-2023-N-0061-0044", "FDA", "FDA-2023-N-0061", "Memorandum - Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (Proposed Rule)", "Other", "Memorandum", "2024-11-06T05:00:00Z", 2024, 11, "2024-11-06T05:00:00Z", null, "2024-11-06T17:00:18Z", null, 0, 0, "09000064867ffe78"], ["FDA-2023-N-0061-0004", "FDA", "FDA-2023-N-0061", "Reference 02 PCAC transcript March 9 2016", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:37:08Z", null, 0, 0, "0900006486487b7d"], ["FDA-2023-N-0061-0012", "FDA", "FDA-2023-N-0061", "Reference 09 PCAC briefing May 8-9 2017", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:47:41Z", null, 0, 0, "09000064864886b6"], ["FDA-2023-N-0061-0013", "FDA", "FDA-2023-N-0061", "Reference 10a PCAC briefing Nov 20-21 2017", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:48:46Z", null, 0, 0, "09000064864886a3"], ["FDA-2023-N-0061-0007", "FDA", "FDA-2023-N-0061", "Reference 05 PCAC transcript Nov 21 2017", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:40:06Z", null, 0, 0, "0900006486487b80"], ["FDA-2023-N-0061-0001", "FDA", "FDA-2023-N-0061", "Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2024-03-20T04:00:00Z", 2024, 3, "2024-03-20T04:00:00Z", "2024-06-19T03:59:59Z", "2024-06-20T01:00:32Z", "2024-05801", 0, 0, "090000648648745b"], ["FDA-2023-N-0061-0009", "FDA", "FDA-2023-N-0061", "Reference 07a PCAC briefing March 8-9 2016", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:44:38Z", null, 0, 0, "09000064864886b3"], ["FDA-2023-N-0061-0006", "FDA", "FDA-2023-N-0061", "Reference 04 PCAC transcript May 8-9 2017", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:39:08Z", null, 0, 0, "0900006486487b7f"], ["FDA-2023-N-0061-0010", "FDA", "FDA-2023-N-0061", "Reference 07b PCAC briefing March 8-9 2016 errata and addendum", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:45:43Z", null, 0, 0, "09000064864886b4"], ["FDA-2023-N-0061-0008", "FDA", "FDA-2023-N-0061", "Reference 06 PCAC briefing June 17-18 2015", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:41:55Z", null, 0, 0, "09000064864886b2"], ["FDA-2023-N-0061-0003", "FDA", "FDA-2023-N-0061", "Reference 01 PCAC transcript June 18 2015", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:36:09Z", null, 0, 0, "0900006486487b7c"], ["FDA-2023-N-0061-0005", "FDA", "FDA-2023-N-0061", "Reference 03 PCAC transcript Nov 3 2016", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:38:12Z", null, 0, 0, "0900006486487b7e"], ["FDA-2023-N-0061-0011", "FDA", "FDA-2023-N-0061", "Reference 08 PCAC briefing Nov 3 2016", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:46:39Z", null, 0, 0, "09000064864886b5"], ["FDA-2023-N-0061-0002", "FDA", "FDA-2023-N-0061", "Reference Summary List for Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under sections 503A and 503B", "Supporting & Related Material", "Background Material", "2024-03-20T04:00:00Z", 2024, 3, null, null, "2024-03-20T15:34:54Z", null, 0, 0, "0900006486487b7b"]], "truncated": false, "filtered_table_rows_count": 20, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2023-N-0061"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061", "results": [{"value": "FDA", "label": "FDA", "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2023-N-0061", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061", "results": [{"value": 2024, "label": 2024, "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&posted_year=2024", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-0061&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 42.010914999991655, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}